Acrivon Therapeutics, Inc. short interest in 2024
In 2024, Acrivon Therapeutics, Inc.'s disclosed short interest ran from 1.48% of shares outstanding on 12 Jan 2024 to 3.78% on 31 Dec 2024, a change of +2.30 percentage points. The year's high was 5.06% on 28 Jun 2024 and its low 1.48% on 12 Jan 2024, averaging 3.52% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.42 days on 29 Nov 2024. Full history: Acrivon Therapeutics, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.48% (12 Jan 2024)
- End of year
- 3.78% (31 Dec 2024)
- Change
- +2.30 pp
- High
- 5.06% (28 Jun 2024)
- Low
- 1.48% (12 Jan 2024)
- Average
- 3.52%
- Highest days to cover
- 26.42 (29 Nov 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.48% | 4.35 | |
| 31 Jan 2024 | 1.48% | 9.00 | |
| 15 Feb 2024 | 1.68% | 3.95 | |
| 29 Feb 2024 | 1.78% | 5.53 | |
| 15 Mar 2024 | 2.18% | 4.46 | |
| 28 Mar 2024 | 2.35% | 7.72 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 4.53% | 1.00 | |
| 30 Apr 2024 | 4.79% | 3.20 | results (8-K) |
| 15 May 2024 | 4.65% | 6.60 | 10-Q filed, results (8-K) |
| 31 May 2024 | 4.56% | 13.23 | |
| 14 Jun 2024 | 4.60% | 10.77 | |
| 28 Jun 2024 | 5.06% | 6.77 | |
| 15 Jul 2024 | 4.72% | 8.54 | |
| 31 Jul 2024 | 4.56% | 16.58 | |
| 15 Aug 2024 | 3.27% | 17.87 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 3.32% | 15.37 | |
| 13 Sep 2024 | 4.14% | 15.75 | |
| 30 Sep 2024 | 3.90% | 6.49 | |
| 15 Oct 2024 | 3.59% | 12.49 | |
| 31 Oct 2024 | 3.48% | 22.54 | |
| 15 Nov 2024 | 3.57% | 20.92 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 3.58% | 26.42 | |
| 13 Dec 2024 | 3.55% | 17.10 | |
| 31 Dec 2024 | 3.78% | 20.16 |
See also: Acrivon Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.